Article metrics
Other content recommended for you
- Barriers to green inhaler prescribing: ethical issues in environmentally sustainable clinical practice
- Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England
- Towards net zero: asthma care
- Carbon footprint impact of the choice of inhalers for asthma and COPD
- Improving the environmental sustainability of paediatric care
- Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis
- Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
- Inhalers: to switch or not to switch? That is the question
- The president speaks: prevention is best: lessons from protecting the ozone layer
- Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries